Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MGLL | Q99685 | 13/20 | 0.82 |
| ▸ | FAAH | O00519 | 5/20 | 0.82 |
| ▸ | PTGDR2 | Q9Y5Y4 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20566368 | 1.00 | MGLL (0.82) | MGLLFAAHPTGDR2 | |
| SCHEMBL20566370 | 1.00 | MGLL (0.82) | MGLLFAAHPTGDR2 | |
| SCHEMBL25830320 | 0.94 | MGLL (0.72) | MGLLFAAHPTGDR2 | |
| SCHEMBL20567187 | 0.90 | MGLL (1.00) | MGLLFAAH | |
| SCHEMBL30420354 | 0.90 | MGLL (1.00) | MGLLFAAH | |
| SCHEMBL20567694 | 0.90 | MGLL (1.00) | MGLLFAAH | |
| SCHEMBL20567185 | 0.90 | MGLL (1.00) | MGLLFAAH | |
| SCHEMBL30420692 | 0.90 | MGLL (1.00) | MGLLFAAH | |
| SCHEMBL24236000 | 0.89 | MGLL (0.82) | MGLLFAAH | |
| SCHEMBL20567735 | 0.89 | MGLL (0.82) | MGLLFAAH |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220031676-A1 | METHODS OF TREATING DISEASE WITH MAGL INHIBITORS | H. LUNDBECK A/S (DK) | 2022-02-03 | — | — | US | disclosed |
| US-20210053960-A1 | PYRAZOLE MAGL INHIBITORS | H. LUNDBECK A/S (DK) | 2021-02-25 | — | — | US | disclosed |
| US-10266497-B2 | Pyrazole MAGL inhibitors | ABIDE THERAPEUTICS, INC. (US) | 2019-04-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10266497-B2 | Pyrazole MAGL inhibitors | MGLL, PNLIP, LPL | MGLL 1/4885FAAH 33/4885PTGDR2 907/4885 |
| US-20210053960-A1 | PYRAZOLE MAGL INHIBITORS | MGLL, PNLIP, LPL | MGLL 1/4885FAAH 33/4885PTGDR2 907/4885 |
| US-20220031676-A1 | METHODS OF TREATING DISEASE WITH MAGL INHIBITORS | MGLL, LIPA, PNLIP | MGLL 1/4885FAAH 67/4885PTGDR2 1998/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.